Abstract
The complement system has long been known to be a major element of innate immunity. Traditionally, it was regarded as the first line of defense against invading pathogens, leading to opsonization and phagocytosis or the direct lysis of microbes. However, from the second half of the twentieth century on, it became clear that complement is also intimately involved in the induction and “fine tuning” of adaptive B- and T-cell responses as well as lineage commitment. This growing recognition of the complement system’s multifunctional role in immunity is consistent with the recent paradigm that complement is also necessary for the successful contraction of an adaptive immune response. This review aims at giving a condensed overview of complement’s rise from a simple innate stop-and-go system to an essential and efficient participant in general immune homeostasis and acquired immunity.
Similar content being viewed by others
References
Agnello V, De Bracco MM, Kunkel HG (1972) Hereditary C2 deficiency with some manifestations of systemic lupus erythematosus. J Immunol 108: 837–840
Agrawal A, Eastman QM, Schatz DG (1998) Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature 394: 744–751
Alford SK, Longmore GD, Stenson WF et al (2008) CD46–induced immunomodulatory CD4+ T cells express the adhesion molecule and chemokine receptor pattern of intestinal T cells. J Immunol 181: 2544–2555
Al-Sharif WZ, Sunyer JO, Lambris JD et al (1998) Sea urchin coelomocytes specifically express a homologue of the complement component C3. J Immunol 160: 2983–2997
Astier AL, Meiffren G, Freeman S et al (2006) Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J Clin Invest 116: 3252–3257
Astier A, Trescol-Biemont MC, Azocar O et al (2000) Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J Immunol 164: 6091–6095
Azumi K, De Santis R, De Tomaso A et al (2003) Genomic analysis of immunity in a Urochordate and the emergence of the vertebrate immune system: “waiting for Godot”. Immunogenetics 55: 570–581
Barrington RA, Pozdnyakova O, Zafari MR et al (2002) B lymphocyte memory: role of stromal cell complement and FcgammaRIIB receptors. J Exp Med 196: 1189–1199
Bernet J, Mullick J, Singh AK et al (2003) Viral mimicry of the complement system. J Biosci 28: 249–264
Bonifati DM, Kishore U (2007) Role of complement in neurodegeneration and neuroinflammation. Mol Immunol 44: 999–1010
Bordet J, Gengou O (1901) Sur l’existence de substances sensibilisatrices dans la plupart des serums antimicrobiens. Ann De l’Inst Pasteur 15: 289–303
Botto M, Dell’Agnola C, Bygrave AE et al (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19: 56–59
Brown KM, Sacks SH, Sheerin NS (2007) Mechanisms of disease: the complement system in renal injury – new ways of looking at an old foe. Nat Clin Pract Nephrol 3: 277–286
Capasso M, Durrant LG, Stacey M et al (2006) Costimulation via CD55 on human CD4+ T cells mediated by CD97. J Immunol 177: 1070–1077
Carroll MC (2004) The complement system in B cell regulation. Mol Immunol 41: 141–146
Carroll MC (2004) The complement system in regulation of adaptive immunity. Nat Immunol 5: 981–986
Cattaneo R (2004) Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens’ magnet. J Virol 78: 4385–4388
Ciurana CL, Zwart B, van Mierlo G et al (2004) Complement activation by necrotic cells in normal plasma environment compares to that by late apoptotic cells and involves predominantly IgM. Eur J Immunol 34: 2609–2619
Davis AE 3rd (2005) The pathophysiology of hereditary angioedema. Clin Immunol 114: 3–9
Day NK, Geiger H, McLean R et al (1973) C2 deficiency. Development of lupus erythematosus. J Clin Invest 52: 1601–1607
Dempsey PW, Allison ME, Akkaraju S et al (1996) C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271: 348–350
Diamond LE, Quinn CM, Martin MJ et al (2001) A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation 71: 132–142
Dishaw LJ, Smith SL, Bigger CH (2005) Characterization of a C3-like cDNA in a coral: phylogenetic implications. Immunogenetics 57: 535–548
Drouin SM, Corry DB, Kildsgaard J et al (2001) Cutting edge: the absence of C3 demonstrates a role for complement in Th2 effector functions in a murine model of pulmonary allergy. J Immunol 167: 4141–4145
Du Pasquier L, Litman GW (2000) Origin and evolution of the vertebrate immune system. Springer Edition, Berlin
Ehrlich P (1960) The collected papers of Paul Ehrlich. In: Himmelweit F, Marquardt M, Dale H (eds) Histology, biochemistry and pathology 1956, immunology and cancer research 1957, chemotherapy 1960 Chapter. Pergamon Press, London Oxford-New York-Paris
Elward K, Griffiths M, Mizuno M et al (2005) CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells. J Biol Chem 280: 36342–36354
Fadok VA, Bratton DL, Konowal A et al (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101: 890–898
Fang C, Miwa T, Shen H et al (2007) Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice. J Immunol 179: 3178–3186
Fearon DT, Wong WW (1983) Complement ligand-receptor interactions that mediate biological responses. Annu Rev Immunol 1: 243–271
Fischer WH, Hugli TE (1997) Regulation of B cell functions by C3a and C3a(desArg): suppression of TNF-alpha, IL-6, and the polyclonal immune response. J Immunol 159: 4279–4286
Fishelson Z, Attali G, Mevorach D (2001) Complement and apoptosis. Mol Immunol 38: 207–219
Fleming SD, Shea-Donohue T, Guthridge JM et al (2002) Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J Immunol 169: 2126–2133
Frade R (1999) Structure and functions of proteases which cleave human C3 and are expressed on normal or tumor human cells: some are involved in tumorigenic and metastatic properties of human melanoma cells. Immunopharmacology 42: 39–45
Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J et al (2004) Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 41: e84
Fremeaux-Bacchi V, Moulton EA, Kavanagh D et al (2006) Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol 17: 2017–2025
Galli SJ, Grimbaldeston M, Tsai M (2008) Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 8: 478–486
Gerard NP, Gerard C (2002) Complement in allergy and asthma. Curr Opin Immunol 14: 705–708
Ghannam A, Hammache D, Matias C (2008) High-density rafts preferentially host the complement activator measles virus F glycoprotein but not the regulators of complement activation. Mol Immunol 45: 3036–3044
Gorter A, Meri S (1999) Immune evasion of tumor cells using membrane-bound complement regulatory proteins. Immunol Today 20: 576–582
Grossman WJ, Ley TJ (2004) Granzymes A and B are not expressed in human neutrophils. Blood 104:906--907; author reply 907--908
Grossman WJ, Verbsky JW, Barchet W et al (2004) Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21: 589–601
Guo RF, Ward PA (2005) Role of C5a in inflammatory responses. Annu Rev Immunol 23: 821–852
Hansch GM, Hammer CH, Vanguri P et al (1981) Homologous species restriction in lysis of erythrocytes by terminal complement proteins. Proc Natl Acad Sci USA 78: 5118–5121
Hara T, Matsumoto M, Tsuji S et al (1996) Homologous complement activation on drug-induced apoptotic cells from a human lung adenocarcinoma cell line. Immunobiology 196: 491–503
Hardy RR, Hayakawa K (2001) B cell development pathways. Annu Rev Immunol 19: 595–621
Hawlisch H, Belkaid Y, Baelder R et al (2005) C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity 22: 415–426
Hawlisch H, Kohl J (2006) Complement and Toll-like receptors: key regulators of adaptive immune responses. Mol Immunol 43: 13–21
Heeger PS, Lalli PN, Lin F et al (2005) Decay-accelerating factor modulates induction of T cell immunity. J Exp Med 201: 1523–1530
Helmy KY, Katschke KJ Jr, Gorgani NN et al (2006) CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124: 915–927
Hill A, Richards SJ, Hillmen P (2007) Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria. Br J Haematol 137: 181–192
Hiom K, Melek M, Gellert M (1998) DNA transposition by the RAG1 and RAG2 proteins: a possible source of oncogenic translocations. Cell 94: 463–470
Holme ER, Veitch J, Johnston A et al (1989) Familial properdin deficiency associated with chronic discoid lupus erythematosus. Clin Exp Immunol 76: 76–81
Hourcade DE (2006) The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J Biol Chem 281: 2128–2132
Jacquier-Sarlin MR, Gabert FM, Villiers MB et al (1995) Modulation of antigen processing and presentation by covalently linked complement C3b fragment. Immunology 84: 164–170
Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20: 197–216
Janeway C, Murphy KP, Travers P et al (2008) Janeway’s immunobiology, 7th edn. Garland Science, New York, NY
Jensen JA, Festa E, Smith DS et al (1981) The complement system of the nurse shark: hemolytic and comparative characteristics. Science 214: 566–569
Jones J, Morgan BP (1995) Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes: functional relevance and role in inflammation. Immunology 86: 651–660
Kang YS, Do Y, Lee HK et al (2006) A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q. Cell 125: 47–58
Karp CL, Grupe A, Schadt E et al (2000) Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat Immunol 1: 221–226
Karp CL, Wysocka M, Wahl LM et al (1996) Mechanism of suppression of cell-mediated immunity by measles virus. Science 273: 228–231
Kavanagh D, Richards A, Atkinson J (2008) Complement regulatory genes and hemolytic uremic syndromes. Annu Rev Med 59: 293–309
Kawano M, Tsunoda S, Koni I et al (1997) Decreased expression of 20-kD homologous restriction factor (HRF20, CD59) on T lymphocytes in Epstein-Barr virus (EBV)-induced infectious mononucleosis. Clin Exp Immunol 108: 260–265
Kemper C, Atkinson JP (2007) T-cell regulation: with complements from innate immunity. Nat Rev Immunol 7: 9–18
Kemper C, Chan AC, Green JM et al (2003) Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421: 388–392
Kemper C, Mitchell LM, Zhang L et al (2008) The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis. Proc Natl Acad Sci USA 105: 9023–9028
Kemper C, Verbsky JW, Price JD et al (2005) T-cell stimulation and regulation: with complements from CD46. Immunol Res 32: 31–43
Kerekes K, Cooper PD, Prechl J et al (2001) Adjuvant effect of gamma-inulin is mediated by C3 fragments deposited on antigen-presenting cells. J Leukoc Biol 69: 69–74
Kim AH, Dimitriou ID, Holland MC et al (2004) Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses. J Immunol 173: 2524–2529
Kohl J, Baelder R, Lewkowich IP et al (2006) A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J Clin Invest 116: 783–796
Kopf M, Abel B, Gallimore A et al (2002) Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat Med 8: 373–378
Korb LC, Ahearn JM (1997) C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 158: 4525–4528
Kuhn R, Lohler J, Rennick D et al (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263–274
Kvell K, Cooper EL, Engelmann P et al (2007) Blurring borders: innate immunity with adaptive features. Clin Dev Immunol 2007: 83671
Lambris JD, Ricklin D, Geisbrecht BV (2008) Complement evasion by human pathogens. Nat Rev Microbiol 6: 132–142
Lewis MJ, Botto M (2006) Complement deficiencies in humans and animals: links to autoimmunity. Autoimmunity 39: 367–378
Li K, Anderson KJ, Peng Q et al (2008) Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood 112: 5084–5094
Lin F, Kaminski HJ, Conti-Fine BM et al (2002) Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection. J Clin Invest 110: 1269–1274
Lin F, Spencer D, Hatala DA et al (2004) Decay-accelerating factor deficiency increases susceptibility to dextran sulfate sodium-induced colitis: role for complement in inflammatory bowel disease. J Immunol 172: 3836–3841
Litman GW, Cannon JP, Dishaw LJ (2005) Reconstructing immune phylogeny: new perspectives. Nat Rev Immunol 5: 866–879
Liu J, Miwa T, Hilliard B et al (2005) The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J Exp Med 201: 567–577
Longhi MP, Harris CL, Morgan BP et al (2006) Holding T cells in check – a new role for complement regulators. Trends Immunol 27: 102–108
Longhi MP, Sivasankar B, Omidvar N et al (2005) Cutting edge: murine CD59a modulates antiviral CD4+ T cell activity in a complement-independent manner. J Immunol 175: 7098–7102
Loveland BE, Milland J, Kyriakou P et al (2004) Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non- -immunosuppressed baboons. Xenotransplantation 11: 171–183
Machado F, Esper L, Dias A et al (2008) Pathogen-driven CCR5-C5aR heterodimerization initiates a JNK2/JIP1-dependent signaling pathway that protects from Toxoplasma gondii infection. Mol Immumol 45: 4110
Manderson AP, Botto M, Walport MJ (2004) The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 22: 431–456
Marie JC, Astier AL, Rivailler P et al (2002) Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat Immunol 3: 659–666
Markiewski MM, DeAngelis RA, Benencia F et al (2008) Modulation of the antitumor immune response by complement. Nat Immunol 9: 1225–1235
Markiewski MM, Lambris JD (2007) The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol 171: 715–727
Markiewski MM, Nilsson B, Ekdahl KN et al (2007) Complement and coagulation: strangers or partners in crime. Trends Immunol 28: 184–192
Marth T, Kelsall BL (1997) Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med 185: 1987–1995
Martinez-Forero I, Garcia-Munoz R, Martinez-Pasamar S et al (2008) IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis. Eur J Immunol 38: 576–586
Matsumoto AK, Martin DR, Carter RH et al (1993) Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J Exp Med 178: 1407–1417
Matsushita M, Endo Y, Fujita T (1998) MASP1 (MBL-associated serine protease 1). Immunobiology 199: 340–347
Matsushita M, Matsushita A, Endo Y et al (2004) Origin of the classical complement pathway: Lamprey orthologue of mammalian C1q acts as a lectin. Proc Natl Acad Sci USA 101: 10127–10131
Medzhitov R, Janeway C Jr (2000) Innate immunity. N Engl J Med 343: 338–344
Meri S, Pangburn MK (1994) Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H. Biochem Biophys Res Commun 198: 52–59
Miller DJ, Hemmrich G, Ball EE et al (2007) The innate immune repertoire in cnidaria – ancestral complexity and stochastic gene loss. Genome Biol 8: R59
Morgan BP, Harris CL (1999) Complement Regulatory Proteins. Academic Press, London, UK
Morgan BP, Marchbank KJ, Longhi MP et al (2005) Complement: central to innate immunity and bridging to adaptive responses. Immunol Lett 97: 171–179
Mullighan CG, Marshall SE, Welsh KI (2000) Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in common variable immunodeficiency. Scand J Immunol 51: 111–122
Nathan C (2006) Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6: 173–182
Nauta AJ, Raaschou-Jensen N, Roos A et al (2003) Mannose- -binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol 33: 2853–2863
Nauta AJ, Trouw LA, Daha MR et al (2002) Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol 32: 1726–1736
Nicholson-Weller A, Halperin JA (1993) Membrane signaling by complement C5b-9, the membrane attack complex. Immunol Res 12: 244–257
Niculescu F, Rus H (2001) Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells. Immunol Res 24: 191–199
Nonaka M, Kimura A (2006) Genomic view of the evolution of the complement system. Immunogenetics 58: 701–713
Nonaka M, Takahashi M, Sasaki M (1994) Molecular cloning of a lamprey homologue of the mammalian MHC class III gene, complement factor B. J Immunol 152: 2263–2269
Noris M, Brioschi S, Caprioli J et al (2003) Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 362: 1542–1547
Nussenzweig V, Bianco C, Dukor P et al (1971) Receptors for C3 on B lymphocytes: Possible Role in the Immune Response. Academic Press Edition, New York
O’Garra A, Vieira P (2004) Regulatory T cells and mechanisms of immune system control. Nat Med 10: 801–805
Ogden CA, deCathelineau A, Hoffmann PR et al (2001) C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 194: 781–795
Ohlenschlaeger T, Garred P, Madsen HO et al (2004) Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 351: 260–267
Ottonello L, Corcione A, Tortolina G et al (1999) rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues. J Immunol 162: 6510–6517
Pangburn MK, Rawal N (2002) Structure and function of complement C5 convertase enzymes. Biochem Soc Trans 30: 1006–1010
Pappworth IY, Kulik L, Haluszczak C et al (2009) Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21). Mol Immunol 46: 1042–1049
Pepys MB (1972) Role of complement in induction of the allergic response. Nat New Biol 237: 157–159
Pickering MC, Botto M, Taylor PR et al (2000) Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 76: 227–324
Pickering MC, Cook HT, Warren J et al (2002) Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 31: 424–428
Potempa M, Potempa J, Kantyka T et al (2009) Interpain A, a cysteine proteinase from Prevotella intermedia, inhibits complement by degrading complement factor C3. PLoS Pathog 5: e1000316
Pratt JR, Basheer SA, Sacks SH (2002) Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 8: 582–587
Prodeus AP, Goerg S, Shen LM et al (1998) A critical role for complement in maintenance of self-tolerance. Immunity 9: 721–731
Reid RR, Woodcock S, Shimabukuro-Vornhagen A et al (2002) Functional activity of natural antibody is altered in Cr2- -deficient mice. J Immunol 169: 5433–5440
Richards A, Kemp EJ, Liszewski MK et al (2003) Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci USA 100: 12966–12971
Ricklin D, Lambris JD (2007) Complement-targeted therapeutics. Nat Biotechnol 25: 1265–1275
Riley-Vargas RC, Gill DB, Kemper C et al (2004) CD46: expanding beyond complement regulation. Trends Immunol 25: 496–503
Rubtsov YP, Rasmussen JP, Chi EY et al (2008) Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28: 546–558
Rugonfalvi-Kiss S, Endresz V, Madsen HO et al (2002) Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin. Circulation 106: 1071–1076
Rushmere NK, Tomlinson S, Morgan BP (1997) Expression of rat CD59: functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for function. Immunology 90: 640–646
Sadlack B, Merz H, Schorle H et al (1993) Ulcerative colitis–like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253–261
Sanchez A, Feito MJ, Rojo JM (2004) CD46-mediated costimulation induces a Th1-biased response and enhances early TCR/CD3 signaling in human CD4+ T lymphocytes. Eur J Immunol 34: 2439–2448
Savill J, Dransfield I, Gregory C et al (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2: 965–975
Savill J, Fadok V (2000) Corpse clearance defines the meaning of cell death. Nature 407: 784–788
Sjoholm AG, Jonsson G, Braconier JH et al (2006) Complement deficiency and disease: an update. Mol Immunol 43: 78–85
Smith LC, Shih CS, Dachenhausen SG (1998) Coelomocytes express SpBf, a homologue of factor B, the second component in the sea urchin complement system. J Immunol 161: 6784–6793
Soane L, Cho HJ, Niculescu F et al (2001) C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway. J Immunol 167: 2305–2311
Spahn TW, Kucharzik T (2004) Modulating the intestinal immune system: the role of lymphotoxin and GALT organs. Gut 53: 456–465
Spitzer D, Mitchell LM, Atkinson JP et al (2007) Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J Immunol 179: 2600–2608
Stager S, Alexander J, Kirby AC et al (2003) Natural antibodies and complement are endogenous adjuvants for vaccine- -induced CD8+ T-cell responses. Nat Med 9: 1287–1292
Strainic MG, Liu J, Huang D et al (2008) Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 28: 425–435
Stuart LM, Takahashi K, Shi L et al (2005) Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J Immunol 174: 3220–3226
Suresh M, Molina H, Salvato MS et al (2003) Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection. J Immunol 170: 788–794
Suzuki MM, Satoh N, Nonaka M (2002) C6-like and C3-like molecules from the cephalochordate, amphioxus, suggest a cytolytic complement system in invertebrates. J Mol Evol 54: 671–679
Takahashi M, Iwaki D, Matsushita A et al (2006) Cloning and characterization of mannose-binding lectin from lamprey (Agnathans). J Immunol 176: 4861–4868
Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21: 335–376
Terado T, Okamura K, Ohta Y et al (2003) Molecular cloning of C4 gene and identification of the class III complement region in the shark MHC. J Immunol 171: 2461–2466
Thiel S (2007) Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol Immunol 44: 3875–3888
Tsujimura A, Shida K, Kitamura M et al (1998) Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells. Biochem J 330(Pt 1): 163–168
Varela JC, Atkinson C, Woolson R et al (2008) Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti-MUC1 antibody immune selection. Int J Cancer 123: 1357–1363
Verschoor A, Brockman MA, Gadjeva M et al (2003) Myeloid C3 determines induction of humoral responses to peripheral herpes simplex virus infection. J Immunol 171: 5363–5371
Volanakis JE, Frank MM (1998) The Human Complement System in Health and Disease. Marcel Dekker, Inc, New York
Wagner C, Hansch GM (2006) Receptors for complement C3 on T-lymphocytes: relics of evolution or functional molecules. Mol Immunol 43: 22–30
Walport MJ (2001) Complement. First of two parts. N Engl J Med 344: 1058–1066
Walport MJ (2001) Complement. Second of two parts. N Engl J Med 344: 1140–1144
Warwicker P, Goodship TH, Donne RL et al (1998) Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 53: 836–844
Warwicker P, Goodship TH, Goodship JA (1997) Three new polymorphisms in the human complement factor H gene and promoter region. Immunogenetics 46: 437–438
Wetsel RA (1995) Structure, function and cellular expression of complement anaphylatoxin receptors. Curr Opin Immunol 7: 48–53
Xu Y, Narayana SV, Volanakis JE (2001) Structural biology of the alternative pathway convertase. Immunol Rev 180: 123–135
Zhang X, Kimura Y, Fang C et al (2007) Regulation of Toll–like receptor-mediated inflammatory response by complement in vivo. Blood 110: 228–236
Zhou W, Patel H, Li K et al (2006) Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. Blood 107: 2461–2469
Zhu Y, Thangamani S, Ho B et al (2005) The ancient origin of the complement system. EMBO J 24: 382–394
Zipfel PF, Wurzner R, Skerka C (2007) Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol Immunol 44:3850–3857
Zwart B, Ciurana C, Rensink I et al (2004) Complement activation by apoptotic cells occurs predominantly via IgM and is limited to late apoptotic (secondary necrotic) cells. Autoimmunity 37: 95–102
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s00005-010-0078-x
About this article
Cite this article
Friec, G.L., Kemper, C. Complement: coming full circle. Arch. Immunol. Ther. Exp. 57, 393–407 (2009). https://doi.org/10.1007/s00005-009-0047-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00005-009-0047-4